JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review

Published online March 31, 2026

Increasingly, therapeutic advancements in dermatology favor targeted modalities, such as monoclonal antibodies and biologic therapies, ...

read more
Exosome-Based Therapies in Dermatology: A Scoping Review

Published online March 31, 2026

Exosomes are extracellular vesicles released by cells that transfer proteins, lipids, mRNAs, and microRNAs to recipient cells playing a...

read more
An Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color

Published online March 31, 2026

Post-inflammatory hyperpigmentation (PIH) is a common acquired condition resulting from an overproduction of melanin or abnormal deposi...

read more
Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations

Published online March 31, 2026

Hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, solar lentigines, and drug-induced pigmentation are c...

read more
Eruptive Lentiginosis Within Resolved Psoriasis Plaques: A Case Report and Systematic Review of the Literature

Published online March 30, 2026

Psoriasis is a chronic inflammatory skin condition, affecting approximately three percent of the United States population. While modern...

read more
Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis

Published online March 30, 2026

Acne vulgaris is one of the most common chronic dermatologic conditions globally and often significantly affects quality of life. For m...

read more
Patient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis

Published online March 30, 2026

In recent years, there has been a notable increase in attention to and financial support for dermatology. 1,2 Skin conditions now rank...

read more
Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders

Published online March 30, 2026

Nail disorders encompass a broad spectrum of infectious, inflammatory, neoplastic, and traumatic conditions that may present with overl...

read more
The State of Primary Hyperhidrosis: Therapeutic Advancements and National Representation

Published online March 30, 2026

Hyperhidrosis (HH) is defined as excessive sweating beyond the physiologic requirements of thermoregulation. 1 HH is classified as eit...

read more
The Dermoepidermal Junction as the Initiation Point for Reversal of Dermatoporosis

Published online March 30, 2026

Dermatoporosis is a term first coined by Kaya and Saurat in 2007, describing progressive skin thinning, extracellular matrix (ECM) degr...

read more
Objective Measures Needed: Dermatology Program Directors' Perspectives on the USMLE Step 1 Pass/Fail Transition

Published online March 30, 2026

The United States Medical Licensing Examination (USMLE) will stop reporting a 3-digit numerical score and begin reporting a pass/fail o...

read more
Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions

Published online March 26, 2026

Chronic spontaneous urticaria (CSU) is a chronic, debilitating condition characterized by recurrent wheals and/or angioedema. 1 Sympto...

read more
Association Between Topical Ruxolitinib Treatment and Psychiatric Outcomes in Adults With Vitiligo

Published online March 25, 2026

Vitiligo is a chronic autoimmune skin disorder characterized by progressive loss of epidermal melanocytes, resulting in depigmented mac...

read more
Delays in Medical Care Among Skin of Color Melanoma Patients: A Population-Based Study

Published online March 25, 2026

In the United States (US), the incidence of melanoma, the most aggressive and fatal type of skin cancer, has been increasing at an aver...

read more
Rapid Clearance of Lichen Planus With Topical Tapinarof

Published online March 25, 2026

Lichen Planus (LP) is an auto-inflammatory idiopathic condition with unclear etiology, believed to be an auto-reactive response of T-ce...

read more
Beyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis

Published online March 24, 2026

Seborrheic dermatitis (SD) is a chronic, relapsing inflammatory condition. SD affects areas that are rich in sebaceous glands, most com...

read more
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training

Published online March 13, 2026

Over-the-counter (OTC) products are often used as firstline or adjunctive treatments for many dermatologic conditions. 1,2 Topical for...

read more
The Safety of GLP1 Receptor Agonist Usage in Mohs Micrographic Surgery Patients

Published online March 13, 2026

To the Editor, Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are widely prescribed for type 2 diabetes and, more recently, for obesity man...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

| Aesthetics, Alopecia, Featured Articles, Hair, JDD Re:View, Latest News | No Comments
What’s New in Hair Restoration Check out this clip with Dr. Jacob Beer as he shares the latest advancements in hair restoration.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
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

| Aesthetics, Alopecia, Featured Articles, Hair, JDD Re:View, Latest News | No Comments
Hair Disorders and Treatments   Hair treatments have proliferated in the past several years. While prior treatment options were limited to topical minoxidil and oral finasteride for androgenetic alopecia (AGA),…
Journal of Drugs in Dermatology JDD Article about Rapid Clearance of Lichen Planus With Topical Tapinarof

Rapid Clearance of Lichen Planus With Topical Tapinarof

| Featured Articles, Latest News, Medical Derm | No Comments
Topical tapinarof associated with rapid resolution of shin lichen planus in a treatment resistant patient This is a must-read case report in JDD. The report describes a 70-year-old woman with…
Journal of Drugs in Dermatology JDD Article about Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

| Alopecia, Featured Articles, Latest News | No Comments
A practical review of efficacy, safety, and real world considerations for advanced practice providers This is a must-read JDD article on JAK inhibitors for alopecia areata. The review summarizes current…

Proximal Subungual Onychomycosis in the Immunocompetent: A Case Report and Review of the Literature

| Featured Articles, Latest News, Nails | No Comments
From the Vault: Pulled due to increased interest in rare onychomycosis presentations This case report dates back to JDD’s April 2018 issue. It’s a case report describing a healthy 51-year-old…
Journal of Drugs in Dermatology JDD Article about Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

| Featured Articles, Latest News, Psoriasis | No Comments
Updated long term and real world evidence on efficacy and safety This is a must-read JDD article on brodalumab in plaque psoriasis. The review summarizes long term clinical trial findings,…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Shine a Light on V: Impact, Insights, and Inventive Treatment Strategies for Vitiligo

| Dermatology Podcast Archives, Featured Podcast, Podcast Highlights | No Comments
j iTunes TuneIn Spotify Dr. Iltefat Hamzavi & Adam Friedman, MD, FAAD Often dismissed as a cosmetic issue, Vitiligo is anything but as it has a tremendous impact on quality…
Tune In

Follow Us